Overview

A Study for Participants With Major Depression

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
This is a study to assess the safety and effectiveness of LY2216684 compared to placebo in treating adults with major depressive disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Citalopram
Dexetimide
Phenylethyl Alcohol